Thomas Berger Selected Research

Atrioventricular Block

9/2011	Duration of the A(H)-A(Md) interval predicts occurrence of AV-block after radiofrequency ablation of the slow pathway.
11/2006	Single-beat noninvasive imaging of cardiac electrophysiology of ventricular pre-excitation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Thomas Berger Research Topics

Disease

120	Multiple Sclerosis 05/2024 - 10/2002
24	Demyelinating Diseases (Demyelinating Disease) 01/2023 - 09/2003
18	Neuromyelitis Optica (Devic's Disease) 01/2023 - 11/2009
16	Relapsing-Remitting Multiple Sclerosis 08/2023 - 08/2012
12	COVID-19 03/2023 - 01/2020
12	Inflammation (Inflammations) 01/2022 - 02/2007
10	Infections 01/2024 - 06/2004
10	Disease Progression 01/2023 - 10/2005
9	Ganglion Cysts (Ganglion) 01/2023 - 10/2020
9	Encephalitis (Encephalitis, Rasmussen) 11/2021 - 07/2008
8	Progressive Multifocal Leukoencephalopathy 09/2023 - 10/2005
8	Neoplasms (Cancer) 12/2021 - 03/2006
7	Optic Neuritis (Retrobulbar Neuritis) 12/2022 - 12/2011
7	Acute Disseminated Encephalomyelitis (Postinfectious Encephalomyelitis) 11/2017 - 03/2011
5	Autoimmune Diseases (Autoimmune Disease) 06/2023 - 01/2016
5	Transverse Myelitis (Necrotizing Myelitis) 01/2021 - 12/2011
5	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2021 - 11/2017
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 01/2012
4	Autoimmune Diseases of the Nervous System 01/2022 - 10/2017
4	Neuroinflammatory Diseases 01/2022 - 11/2010
4	Central Nervous System Diseases (CNS Diseases) 01/2020 - 10/2013
3	Pain (Aches) 03/2024 - 06/2005
3	Xerostomia 02/2023 - 10/2022
3	Fatigue 10/2022 - 10/2015
3	Chronic Progressive Multiple Sclerosis 12/2021 - 08/2020
3	Seizures (Absence Seizure) 12/2021 - 11/2012
3	Myelitis 01/2021 - 05/2010
3	Nervous System Diseases (Neurological Disorders) 11/2020 - 12/2003
3	Melanoma (Melanoma, Malignant) 04/2017 - 12/2002
3	Guillain-Barre Syndrome 10/2011 - 06/2008
2	Rupture 11/2023 - 12/2022
2	Mastitis 01/2023 - 11/2022
2	Hemolysis 01/2022 - 01/2021
2	Wounds and Injuries (Trauma) 11/2021 - 06/2004
2	Mental Disorders (Mental Disorder) 01/2018 - 01/2014
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 12/2011 - 05/2010
2	Atrioventricular Block 09/2011 - 11/2006
2	Wolff-Parkinson-White Syndrome (Wolf-Parkinson-White Syndrome) 02/2009 - 11/2006

Drug/Important Bio-Agent (IBA)

38	AntibodiesIBA 01/2023 - 07/2003
30	Biomarkers (Surrogate Marker)IBA 03/2024 - 01/2006
23	Myelin-Oligodendrocyte GlycoproteinIBA 01/2023 - 10/2002
19	Natalizumab (Tysabri)FDA Link 09/2023 - 10/2005
15	Retinaldehyde (Retinal)IBA 01/2023 - 03/2014
14	AutoantibodiesIBA 11/2022 - 12/2003
11	Immunoglobulin G (IgG)IBA 10/2023 - 06/2008
9	Fingolimod Hydrochloride (FTY720)FDA Link 06/2023 - 08/2012
8	IronIBA 01/2024 - 01/2017
8	Complement System Proteins (Complement)IBA 01/2023 - 09/2003
6	Alemtuzumab (Campath)FDA Link 05/2024 - 01/2017
6	nitazoxanide (NTZ)FDA Link 06/2023 - 11/2019
6	Proteins (Proteins, Gene)FDA Link 12/2022 - 06/2003
6	VaccinesIBA 01/2022 - 04/2017
5	ocrelizumabIBA 04/2024 - 08/2020
5	Monoclonal AntibodiesIBA 01/2024 - 06/2003
5	Interferon-betaIBA 06/2023 - 12/2009
5	Glatiramer Acetate (Copaxone)FDA Link 06/2023 - 12/2009
5	Rituximab (Mabthera)FDA Link 01/2021 - 05/2013
4	ChemokinesIBA 01/2023 - 07/2008
4	CytokinesIBA 01/2023 - 04/2019
4	Immunoglobulins (Immunoglobulin)IBA 11/2022 - 11/2009
4	DNA (Deoxyribonucleic Acid)IBA 11/2022 - 05/2012
4	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 11/2021 - 01/2015
4	EpitopesIBA 10/2013 - 06/2003
3	teriflunomideIBA 06/2023 - 07/2019
3	Dimethyl FumarateIBA 06/2023 - 07/2019
3	COVID-19 VaccinesIBA 03/2023 - 11/2022
3	SteroidsIBA 10/2022 - 01/2019
3	Adrenal Cortex Hormones (Corticosteroids)IBA 07/2022 - 01/2020
3	Aquaporins (Water Channels)IBA 01/2022 - 12/2011
3	AutoantigensIBA 01/2017 - 01/2007
3	AntigensIBA 06/2008 - 06/2003
2	Cladribine FDA LinkGeneric 06/2023 - 01/2021
2	GlucocorticoidsIBA 06/2023 - 01/2018
2	Protein Isoforms (Isoforms)IBA 01/2021 - 05/2010
2	InterferonsIBA 01/2021 - 01/2018
2	TabletsIBA 11/2020 - 01/2013
2	Oligoclonal BandsIBA 08/2017 - 12/2015
2	Peptides (Polypeptides)IBA 04/2017 - 10/2015
2	4-Aminopyridine (4 Aminopyridine)FDA Link 01/2013 - 11/2012
2	Immunoglobulin M (IgM)IBA 07/2008 - 12/2003
2	Therapeutic UsesIBA 08/2007 - 11/2006
2	CannabinoidsIBA 10/2006 - 06/2005
2	Myelin Basic ProteinIBA 07/2003 - 10/2002
1	SilverIBA 01/2024
1	ofatumumab FDA Link 01/2024
1	PowdersIBA 01/2024

Therapy/Procedure

39	Therapeutics 05/2024 - 10/2003
9	Radiotherapy 02/2023 - 04/2011
4	Aftercare (After-Treatment) 02/2023 - 01/2018
4	Secondary Prevention 01/2023 - 07/2011
4	Cardiac Rehabilitation 05/2021 - 12/2012
4	Proton Therapy 01/2021 - 10/2012
2	Drug Therapy (Chemotherapy) 05/2024 - 03/2010
2	Immunotherapy 01/2022 - 01/2021
2	Radiofrequency Ablation 01/2013 - 09/2011
2	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 01/2012 - 10/2010
2	Catheter Ablation 02/2009 - 11/2006
2	Catheters 11/2006 - 06/2004
1	Analgesia 03/2024
1	Prostheses and Implants (Prosthesis) 01/2024